Aldurazyme Injection, Solution, Concentrate
Product Images NDC 58468-0070

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Aldurazyme (NDC 58468-0070). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Genzyme Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (2.9 mg/5 mL Vial Label)

Label for ALDURAZYME (laronidase) injection, solution, concentrate, 2.9 mg per 5 mL (0.58 mg/mL) single-dose vial. Manufactured by BioMarin Pharmaceutical Inc. and distributed by Genzyme Corporation. The label includes storage instructions and NDC 58468-0070-1.*

FDA Label Image

Principal Display Panel (2.9 mg/5 mL Vial Carton)

Label for ALDURAZYME (laronidase) injection, solution concentrate 2.9 mg/5 mL (0.58 mg/mL) in a single-dose 5 mL vial. The label includes storage instructions, manufacturer information (BioMarin Pharmaceutical Inc.), and distributor (Genzyme Corporation, a Sanofi company). It also lists inactive ingredients such as sodium chloride, sodium phosphate, and polysorbate 80. The label features barcodes, lot number, and NDC 58468-0070-1.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.